3/25
06:01 am
fdmt
Form EFFECT 4D Molecular Therapeutic
Medium
Report
Form EFFECT 4D Molecular Therapeutic
3/10
08:00 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Bizily Scott
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Bizily Scott
3/10
07:59 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kirn David
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kirn David
3/10
07:58 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Mehra Uneek
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Mehra Uneek
3/10
07:58 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kim Robert Young
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kim Robert Young
3/10
07:57 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kamal Fariborz
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kamal Fariborz
2/28
05:08 pm
fdmt
Form POS AM 4D Molecular Therapeutic
Medium
Report
Form POS AM 4D Molecular Therapeutic
2/28
04:57 pm
fdmt
Form S-8 4D Molecular Therapeutic
Medium
Report
Form S-8 4D Molecular Therapeutic
2/28
04:28 pm
fdmt
Form 10-K 4D Molecular Therapeutic For: Dec 31
Medium
Report
Form 10-K 4D Molecular Therapeutic For: Dec 31
2/28
04:16 pm
fdmt
Form 8-K 4D Molecular Therapeutic For: Feb 28
Medium
Report
Form 8-K 4D Molecular Therapeutic For: Feb 28
2/28
04:10 pm
fdmt
Form POSASR 4D Molecular Therapeutic
Medium
Report
Form POSASR 4D Molecular Therapeutic
2/14
06:30 pm
fdmt
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
2/14
06:10 pm
fdmt
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: Venrock Healthcare Capital Partners III, L.P.
Low
Report
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: Venrock Healthcare Capital Partners III, L.P.
2/14
04:22 pm
fdmt
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: BIOTECHNOLOGY VALUE FUND L P
2/14
11:35 am
fdmt
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: JANUS HENDERSON GROUP PLC
2/14
08:42 am
fdmt
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: Deep Track Capital, LP
Medium
Report
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: Deep Track Capital, LP
2/10
05:29 pm
fdmt
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: GOLDMAN SACHS GROUP INC
High
Report
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: GOLDMAN SACHS GROUP INC
2/10
08:38 am
fdmt
Form 8-K 4D Molecular Therapeutic For: Feb 08
High
Report
Form 8-K 4D Molecular Therapeutic For: Feb 08
1/10
08:36 am
fdmt
Form 8-K 4D Molecular Therapeutic For: Jan 10
High
Report
Form 8-K 4D Molecular Therapeutic For: Jan 10